CANO insider trading

Cano Health, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
175
Last 90 days
0
Buys / sells
14% / 22%
Market cap
—

CANO insider activity at a glance

FilingIQ tracks 175 insider transactions for CANO in filings since Jun 7, 2021. The most recent transaction is dated Jun 28, 2024.

Across the full history, 25 open-market purchases and 38 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest CANO Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Frequently asked

How many insider trades does FilingIQ track for CANO?
FilingIQ tracks 175 Form 4 insider transactions for CANO (Cano Health, Inc.), covering filings from Jun 7, 2021 onwards. 0 of those are dated within the last 90 days.
Are CANO insiders net buyers or net sellers?
Across the full Form 4 history for CANO, 25 transactions (14%) were open-market purchases and 38 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CANO insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every CANO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.